Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02559323 · ClinicalTrials.gov registry record
LIVESTRONG Survivorship Care Plan: Continued Data Collection and Follow Up Survey
A clinical trial, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- 2,000
- Enrollment target
NCT02559323 is a clinical trial that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 2,000 participants.
The verdict
NCT02559323 has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- 2,000 participants
- Enrollment target
Study Summary
Cancer survivors face unique health challenges as a result of their cancer diagnosis and treatment. OncoLink created an Internet based program for survivors to learn about their risks. A follow up survey will allow us to continue to develop the program in ways that will benefit users. This survey will need to be conducted via email, which will require the collection of the users email address and a secure method of linking the users care plan questionnaire answers to their survey answers.
Interventions
- OTHER Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2010-05 |
| Est. Completion | 2016-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02559323
The ClinicalTrials.gov registry entry for NCT02559323 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Survey is the first listed.
NCT02559323 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02559323 about?
NCT02559323 is a clinical study titled "LIVESTRONG Survivorship Care Plan: Continued Data Collection and Follow Up Survey". Cancer survivors face unique health challenges as a result of their cancer diagnosis and treatment. OncoLink created an Internet based program for survivors to learn about their risks. A follow up survey will allow us to continue to develop the program in ways that will benefit users. This survey wi...
What is the current status of trial NCT02559323?
This trial is currently completed. The enrollment target is 2,000 participants. The study started on 2010-05. Estimated completion is 2016-07.
What interventions are being tested in trial NCT02559323?
The interventions under investigation include: Survey (OTHER).
Who is sponsoring clinical trial NCT02559323?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.